Reducing avoidable hospital readmissions has been a focus of value-based care. The New England Journal of Medicine found that from 2007 to 2015, risk-adjusted rates of readmission for targeted conditions declined from 21.5% to 17.8%. Given that readmission are stressful for patients and adds significant cost to the healthcare system, providers have been looking for tools that identify when to intervene to attempt to prevent an unnecessary readmission.
CMS Embraces Innovation and Competition
Steve Wiggins with Nick Bluhm and Ryan PardoSeptember 20, 2017
Today, Seema Verma, the Centers for Medicare and Medicaid Services (CMS) Administrator, published a Request for Information seeking feedback on how to lead CMS’s Innovation Center in a new direction. Her statements reflect a belief in competition, consumer empowerment and a willingness to use waivers to enable meaningful innovation.
Remedy in the News
Remedy continues to be a strong advocate for the BPCI program and using bundled payment models as a path to healthcare transformation.>
CMS proposes changes to CJR: 6 key thoughts on what this means for orthopedic bundled payments
Becker's Spine Review | August 18, 2017
Is HHS’ Proposal to Scale Back Mandatory Bundled Payments a Step Back from Value-Based Care? Many Healthcare Experts Say No
Healthcare Informatics | August 18, 2017
Chris Garcia Named CEO of Remedy Partners
Remedy Partners, the nation’s leading bundled payment company, has named Chris Garcia its chief executive officer, effective July 12, 2017. Remedy is well-positioned for accelerated growth as the healthcare industry continues to adopt bundled payments as a core value-based payment strategy.